NCT04884035 2026-02-04Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat LymphomaCelgenePhase 1 Recruiting174 enrolled
NCT04599634 2025-02-04Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed11 enrolled 16 charts